On this week’s Spoon Podcast, SuperGut CEO Marc Washington joins me to speak about why new GLP-1 medicine like Ozempic and Wegovy hold CPG model CEOs up at night time.
These new medicine, which bought their begin as a brand new class of prescription drugs that assist management kind 2 diabetes, have develop into highly regarded in recent times as weight reduction miracle drug. They’re vastly efficient in suppressing appetites and lowering the general calorie consumption of these taking them, a lot in order that some speculate that they might have a major impression on the general demand for meals if, as predicted, tens of tens of millions start to take them in coming years as costs come down and so they develop into out there in additional accessible codecs.
Marc’s firm, SuperGut, creates a pure different to GLP-1 medicine within the type of dietary supplements, snacks and bars. His journey to develop into CEO of SuperGut was born out of a private loss and an opportunity assembly with Dave Friedberg, the CEO of The Manufacturing Board.
You possibly can take heed to our dialog by clicking under, downloading to your gadget, or heading over to Apple Podcasts, Spotify or wherever you take heed to podcasts.
